Post-marketing Pharmacovigilance and Medical Information Market Share To 2022: Grand View Research

New Market Research Reports Title “Post-marketing Pharmacovigilance and Medical Information Market Analysis Size and Segment Forecasts to 2022” Has Been Added to GrandViewResearch.com Report Database

Global post-marketing pharmacovigilance and medical information market is expected to reach USD 5.3 Billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of Adverse Drug Reactions (ADRs) coupled with incorporation of advanced ADR reporting tools is responsible for the overall growth of the post-marketing pharmacovigilance and medical information market. Increased drug consumption can be attributed to rising prevalence of chronic diseases such as tuberculosis that involve multiple drug regimes. 

Rising government initiatives for improvement of pharmacovigilance services and maintenance of medical databases are also responsible for inducing overall growth of post-marketing pharmacovigilance and medical information market. For instance, in December 2015, the USAID Systems for Improved Access to Pharmaceuticals and Services (SIAPS) launched PViMS tool to improve drug safety monitoring in low and middle income countries by helping clinicians, researchers, and regulatory authorities to collect, analyze, and monitor ADRs. 

Browse full research report on Global Post-marketing Pharmacovigilance and Medical Information Market: http://www.grandviewresearch.com/industry-analysis/post-marketing-pharmacovigilance-medical-information-market
Further key findings from the study suggest:

Read detailed report or request for sample of this research report: 
http://www.grandviewresearch.com/industry-analysis/post-marketing-pharmacovigilance-medical-information-market/request

Grand View Research has segmented the global post-marketing pharmacovigilance and medical information market on the basis of type, product, end-useand region: 

Global post-marketing pharmacovigilance type outlook (Revenue, USD Million, 2012 – 2022)

Global post-marketing pharmacovigilance and medical information product outlook(Revenue, USD Million, 2012 – 2022)

Global post-marketing pharmacovigilance and medical information end-use outlook (Revenue, USD Million, 2012 – 2022)

Post-marketing pharmacovigilance and medical information regional outlook (Revenue, USD Million, 2012 – 2022)

Browse more reports of this category by Grand View  Research: http://www.grandviewresearch.com/industry/healthcare-it